Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Microbiology and Immunology
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Open Positions
Programs of Study
Our Faculty
Students & Research Fellows
Publications
News and Events
Toggle News and Events menu options
Events
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Our Faculty
Students & Research Fellows
Publications
News and Events
Home
Publications
You are here
Home
>
Publications
>
Publications
Publications
Found 19 results
Author
Title
[
Type
]
Year
Filters:
Author
is
Klasse, Per Johan
[Clear All Filters]
Journal Article
Klasse PJohan
,
Shattock R
,
Moore JP
. 2008.
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.
.
Annu Rev Med. 59:455-71.
Ketas TJ
,
Schader SM
,
Zurita J
,
Teo E
,
Polonis V
,
Lu M
,
Klasse PJohan
,
Moore JP
. 2007.
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
.
Virology. 364(2):431-40.
Ketas TJ
,
Holuigue S
,
Matthews K
,
Moore JP
,
Klasse PJohan
. 2012.
Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.
.
Virology. 422(1):22-36.
Banerjee K
,
Andjelic S
,
Klasse PJohan
,
Kang Y
,
Sanders RW
,
Michael E
,
Durso RJ
,
Ketas TJ
,
Olson WC
,
Moore JP
. 2009.
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.
.
Virology. 389(1-2):108-21.
Sanders RW
,
van Gils MJ
,
Derking R
,
Sok D
,
Ketas TJ
,
Burger JA
,
Ozorowski G
,
Cupo A
,
Simonich C
,
Goo L
et al.
. 2015.
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.
.
Science. 349(6244):aac4223.
Klasse PJohan
,
Sanders RW
,
Cerutti A
,
Moore JP
. 2012.
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?
AIDS Res Hum Retroviruses. 28(1):1-15.
Pugach P
,
Ray N
,
Klasse PJohan
,
Ketas TJ
,
Michael E
,
Doms RW
,
Lee B
,
Moore JP
. 2009.
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities.
.
Virology. 387(2):296-302.
Burton DR
,
Hessell AJ
,
Keele BF
,
Klasse PJohan
,
Ketas TA
,
Moldt B
,
D Dunlop C
,
Poignard P
,
Doyle LA
,
Cavacini L
et al.
. 2011.
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.
.
Proc Natl Acad Sci U S A. 108(27):11181-6.
Berro R
,
Klasse PJohan
,
Lascano D
,
Flegler A
,
Nagashima KA
,
Sanders RW
,
Sakmar TP
,
Hope TJ
,
Moore JP
. 2011.
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.
.
J Virol. 85(16):8227-40.
Forbes CJ
,
Lowry D
,
Geer L
,
Veazey RS
,
Shattock RJ
,
Klasse PJohan
,
Mitchnick M
,
Goldman L
,
Doyle LA
,
Muldoon BCO
et al.
. 2011.
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
.
J Control Release. 156(2):161-9.
Veazey RS
,
Springer MS
,
Marx PA
,
Dufour J
,
Klasse PJohan
,
Moore JP
. 2005.
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
.
Nat Med. 11(12):1293-4.
Veazey RS
,
Klasse PJohan
,
Schader SM
,
Hu Q
,
Ketas TJ
,
Lu M
,
Marx PA
,
Dufour J
,
Colonno RJ
,
Shattock RJ
et al.
. 2005.
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
.
Nature. 438(7064):99-102.
Anastassopoulou CG
,
Ketas TJ
,
Depetris RS
,
Thomas AM
,
Klasse PJohan
,
Moore JP
. 2011.
Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.
.
Virology. 413(1):47-59.
Anastassopoulou CG
,
Ketas TJ
,
Klasse PJohan
,
Moore JP
. 2009.
Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.
.
Proc Natl Acad Sci U S A. 106(13):5318-23.
W Horne S
,
Johnson LM
,
Ketas TJ
,
Klasse PJohan
,
Lu M
,
Moore JP
,
Gellman SH
. 2009.
Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers.
.
Proc Natl Acad Sci U S A. 106(35):14751-6.
R Malcolm K
,
Veazey RS
,
Geer L
,
Lowry D
,
Fetherston SM
,
Murphy DJ
,
Boyd P
,
Major I
,
Shattock RJ
,
Klasse PJohan
et al.
. 2012.
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
.
Antimicrob Agents Chemother. 56(5):2251-8.
Melchers M
,
Bontjer I
,
Tong T
,
P Y Chung N
,
Klasse PJohan
,
Eggink D
,
Montefiori DC
,
Gentile M
,
Cerutti A
,
Olson WC
et al.
. 2012.
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.
.
J Virol. 86(5):2488-500.
Harris A
,
Borgnia MJ
,
Shi D
,
Bartesaghi A
,
He H
,
Pejchal R
,
Kang YKenneth
,
Depetris R
,
Marozsan AJ
,
Sanders RW
et al.
. 2011.
Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.
.
Proc Natl Acad Sci U S A. 108(28):11440-5.
Veazey RS
,
Ketas TA
,
Klasse PJohan
,
Davison DK
,
Singletary M
,
Green LC
,
Greenberg ML
,
Moore JP
. 2008.
Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249.
.
Proc Natl Acad Sci U S A. 105(30):10531-6.